NUTRA PHARMA CORP. — Revenue by Fiscal Year
16 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/a3a7637f-370e-4229-b5ef-7c3decaa702b/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $257.6k | 2025-01-01 – 2025-12-31 | evidence 0001493152-26-024641 |
| FY 2024 | $246.3k | 2024-01-01 – 2024-12-31 | evidence 0001493152-26-007044 |
| FY 2023 | $205.6k | 2023-01-01 – 2023-12-31 | evidence 0001493152-25-024800 |
| FY 2022 | $145.8k | 2022-01-01 – 2022-12-31 | evidence 0001493152-25-024800 |
| FY 2021 | $97.7k | 2021-01-01 – 2021-12-31 | evidence 0001493152-22-010035 |
| FY 2020 | $51.9k | 2020-01-01 – 2020-12-31 | evidence 0001493152-21-022204 |
| FY 2019 | $104.4k | 2019-01-01 – 2019-12-31 | evidence 0001493152-21-015860 |
| FY 2018 | $130.6k | 2018-01-01 – 2018-12-31 | evidence 0001493152-21-015860 |
| FY 2017 | $121.0k | 2017-01-01 – 2017-12-31 | evidence 0001398432-18-000049 |
| FY 2016 | $168.4k | 2016-01-01 – 2016-12-31 | evidence 0001398432-18-000049 |
| FY 2015 | $291.3k | 2015-01-01 – 2015-12-31 | evidence 0001398432-16-000597 |
| FY 2014 | $594.5k | 2014-01-01 – 2014-12-31 | evidence 0001398432-15-000168 |
| FY 2013 | $104.8k | 2013-01-01 – 2013-12-31 | evidence 0001398432-15-000168 |
| FY 2012 | $203.3k | 2012-01-01 – 2012-12-31 | evidence 0001144204-13-022247 |
| FY 2011 | $159.6k | 2011-01-01 – 2011-12-31 | evidence 0001144204-12-063254 |
| FY 2010 | $1.4M | 2010-01-01 – 2010-12-31 | evidence 0001144204-12-063254 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
NUTRA PHARMA CORP. — all facts · Net Income · Operating Income